Five-year analysis of neoadjuvant dabrafenib and trametinib for stage III melanoma
-
Published:2024-08
Issue:8
Volume:35
Page:739-746
-
ISSN:0923-7534
-
Container-title:Annals of Oncology
-
language:en
-
Short-container-title:Annals of Oncology
Author:
Menzies A.M.ORCID,
Lo S.N.ORCID,
Saw R.P.M.,
Gonzalez M.,
Ch’ng S.,
Nieweg O.E.,
Shannon K.F.,
Ferguson P.M.,
Lee J.,
Emmett L.,
Kapoor R.,
Rawson R.V.,
Stretch J.R.,
Thompson J.F.ORCID,
Spillane A.J.ORCID,
Rizos H.,
Scolyer R.A.ORCID,
Long G.V.ORCID